Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A systematic review and meta-analysis of inflammatory biomarkers in Parkinson’s disease
Yi Qu, Jiangting Li, Qixiong Qin, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective
Deepak Kumar, Mahendra Bishnoi, Kanthi Kiran Kondepudi, et al.
Probiotics and Antimicrobial Proteins (2025)
Closed Access | Times Cited: 2
Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease
Kun Chen, Haoyang Wang, Iqra Ilyas, et al.
Brain Sciences (2023) Vol. 13, Iss. 4, pp. 634-634
Open Access | Times Cited: 35
Effect of 12-Week BMI-Based Vitamin D3 Supplementation in Parkinson’s Disease with Deep Brain Stimulation on Physical Performance, Inflammation, and Vitamin D Metabolites
Zofia Kinga Bytowska, Daria Korewo-Labelle, Paweł Berezka, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10200-10200
Open Access | Times Cited: 28
Point‐Of‐Care Ultra‐Portable Single‐Molecule Bioassays for One‐Health
Eleonora Macchia, Fabrizio Torricelli, Mariapia Caputo, et al.
Advanced Materials (2023) Vol. 36, Iss. 13
Open Access | Times Cited: 24
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Angeliki Zarkali, George E. Thomas, Henrik Zetterberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson’s Disease: A Promising Therapeutic Approach
Y. So, Jae-Ung Lee, Ga-Seung Yang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1071-1071
Open Access | Times Cited: 11
Combating Parkinson’s Disease with Plant-Derived Polyphenols: Targeting Oxidative Stress and Neuroinflammation
Reem M. Gahtani, Shoaib Shoaib, Umme Hani, et al.
Neurochemistry International (2024) Vol. 178, pp. 105798-105798
Closed Access | Times Cited: 10
Early-stage idiopathic Parkinson’s disease is associated with reduced circular RNA expression
B Whittle, Osagie Izuogu, Hannah Lowes, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 9
Decoding the role of the CCL2/CCR2 axis in Alzheimer’s disease and innovating therapeutic approaches: Keeping All options open
Reyhaneh Arfaei, Narges Mikaeili, Fatemeh Daj, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112328-112328
Closed Access | Times Cited: 9
Exosomes-encapsulated biomimetic polydopamine carbon dots with dual-targeting effect alleviate motor and non-motor symptoms of Parkinson's disease via anti-neuroinflammation
Chen Die Yang, Yanhao Song, Mingkai Luo, et al.
International Journal of Biological Macromolecules (2025) Vol. 296, pp. 139724-139724
Closed Access | Times Cited: 1
Roles of Microglia in Neurodegenerative Diseases
Kazuhiro Nakaso
Yonago acta medica (2024) Vol. 67, Iss. 1, pp. 1-8
Open Access | Times Cited: 8
Biomarkers of Parkinson’s Disease: From Basic Research to Clinical Practice
Zi-Lu Ma, Zhangli Wang, Feiyue Zhang, et al.
Aging and Disease (2023)
Open Access | Times Cited: 16
Intranasal cerium oxide nanoparticles improves locomotor activity and reduces oxidative stress and neuroinflammation in haloperidol-induced parkinsonism in rats
Mohammad, Urooj Ahmed Khan, Musarrat Husain Warsi, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Biomarkers in Parkinson’s disease: A state of the art review
Kyla Y. Yamashita, Sweta Bhoopatiraju, Bret Silverglate, et al.
Biomarkers in Neuropsychiatry (2023) Vol. 9, pp. 100074-100074
Open Access | Times Cited: 12
Circulating levels of inflammatory biomarkers in Huntington's disease: A systematic review and meta-analysis
Alireza Soltani Khaboushan, Aysan Moeinafshar, Mohammad Hamed Ersi, et al.
Journal of Neuroimmunology (2023) Vol. 385, pp. 578243-578243
Closed Access | Times Cited: 11
Cytokine activity in Parkinson’s disease
Nicolas Dzamko
Neuronal Signaling (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 11
The Effect of Gut Microbiota-Targeted Interventions on Neuroinflammation and Motor Function in Parkinson’s Disease Animal Models—A Systematic Review
Paul-Ștefan Panaitescu, Vlad Răzniceanu, Ștefania-Maria Mocrei-Rebrean, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 3946-3974
Open Access | Times Cited: 4
Alpha-synuclein fine-tunes neuronal response to pro-inflammatory cytokines
Veronika Sigutova, Wei Xiang, Martin Regensburger, et al.
Brain Behavior and Immunity (2024) Vol. 122, pp. 216-230
Open Access | Times Cited: 4
Gut-brain axis: gut dysbiosis and psychiatric disorders in Alzheimer’s and Parkinson’s disease
Charlotte R. Denman, Sang Myun Park, Junghyun Jo
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 10
Mesoporous polymeric nanoparticles for effective treatment of inflammatory diseases: an in vivo study
Divya Pareek, Md. Zeyaullah, Sukanya Patra, et al.
Journal of Materials Chemistry B (2025)
Closed Access
Higher systemic immune-inflammation index is associated with increased risk of Parkinson’s disease in adults: a nationwide population-based study
Jiayu Zhao, Zhipeng Wu, Fang Cai, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Lack of neuroprotection after systemic administration of the soluble TNF inhibitor XPro1595 in an rAAV6-α-Syn + PFFs-induced rat model for Parkinson's disease
Filip Fredlund, Claes Fryklund, Olivia Trujeque-Ramos, et al.
Neurobiology of Disease (2025), pp. 106841-106841
Open Access
Correlation of inflammatory markers with depression and sleep disorders accompanying the prodromal stage of Parkinson’s disease
Chengguang Zhang, Yu Zhang, Ke Xu, et al.
World Journal of Psychiatry (2025) Vol. 15, Iss. 3
Closed Access
Treadmill exercise mitigates rotenone-induced neuroinflammation and α-synuclein level in a mouse model of Parkinson’s disease
Deepak Kumar, Rohith Kumar, Sushmita Janrao, et al.
Brain Research (2025), pp. 149540-149540
Closed Access
Multi-omics dissection of Parkinson’s patients in subgroups associated with motor and cognitive severity
Efi Athieniti, Sotiroula Afxenti, George Minadakis, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Page 1 - Next Page

Scroll to top